Repligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial GuidanceGlobeNewsWire • 05/05/26
Analysts Estimate Repligen (RGEN) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 04/28/26
Conestoga Capital Small Cap Portfolio Quarterly Scorecard: Buys, Sells, And StandoutsSeeking Alpha • 04/23/26
Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support NetworkGlobeNewsWire • 04/17/26
Repligen (RGEN) Down 13.5% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 03/26/26
Repligen Corporation (RGEN) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum TranscriptSeeking Alpha • 03/18/26
Repligen Corporation (RGEN) Presents at Leerink Global Healthcare Conference 2026 TranscriptSeeking Alpha • 03/10/26
Repligen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial GuidanceGlobeNewsWire • 02/24/26
Repligen Corporation (RGEN) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/14/26
Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected ChairGlobeNewsWire • 01/06/26
Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality WorkflowsGlobeNewsWire • 12/16/25
Repligen Corporation (RGEN) Presents at Evercore 8th Annual Healthcare Conference TranscriptSeeking Alpha • 12/03/25
Repligen Corporation (RGEN) Presents at 7th Annual Wolfe Research Healthcare Conference TranscriptSeeking Alpha • 11/18/25